1. Home
  2. MNOV vs JSPR Comparison

MNOV vs JSPR Comparison

Compare MNOV & JSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MNOV
  • JSPR
  • Stock Information
  • Founded
  • MNOV 2000
  • JSPR 2018
  • Country
  • MNOV United States
  • JSPR United States
  • Employees
  • MNOV N/A
  • JSPR N/A
  • Industry
  • MNOV Biotechnology: Pharmaceutical Preparations
  • JSPR Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • MNOV Health Care
  • JSPR Health Care
  • Exchange
  • MNOV Nasdaq
  • JSPR Nasdaq
  • Market Cap
  • MNOV 91.7M
  • JSPR 82.7M
  • IPO Year
  • MNOV 2005
  • JSPR N/A
  • Fundamental
  • Price
  • MNOV $1.90
  • JSPR $6.14
  • Analyst Decision
  • MNOV Strong Buy
  • JSPR Strong Buy
  • Analyst Count
  • MNOV 1
  • JSPR 11
  • Target Price
  • MNOV $9.00
  • JSPR $67.75
  • AVG Volume (30 Days)
  • MNOV 21.3K
  • JSPR 686.3K
  • Earning Date
  • MNOV 02-18-2025
  • JSPR 03-03-2025
  • Dividend Yield
  • MNOV N/A
  • JSPR N/A
  • EPS Growth
  • MNOV N/A
  • JSPR N/A
  • EPS
  • MNOV N/A
  • JSPR N/A
  • Revenue
  • MNOV N/A
  • JSPR N/A
  • Revenue This Year
  • MNOV N/A
  • JSPR N/A
  • Revenue Next Year
  • MNOV N/A
  • JSPR N/A
  • P/E Ratio
  • MNOV N/A
  • JSPR N/A
  • Revenue Growth
  • MNOV N/A
  • JSPR N/A
  • 52 Week Low
  • MNOV $1.12
  • JSPR $5.25
  • 52 Week High
  • MNOV $2.55
  • JSPR $31.01
  • Technical
  • Relative Strength Index (RSI)
  • MNOV 45.15
  • JSPR 30.01
  • Support Level
  • MNOV $1.87
  • JSPR $5.81
  • Resistance Level
  • MNOV $2.06
  • JSPR $7.06
  • Average True Range (ATR)
  • MNOV 0.08
  • JSPR 0.53
  • MACD
  • MNOV 0.00
  • JSPR 0.60
  • Stochastic Oscillator
  • MNOV 47.48
  • JSPR 40.26

About MNOV Medicinova Inc

MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's current strategy is to focus its development activities on therapeutics for neurological disorders and fibrotic diseases.

About JSPR Jasper Therapeutics Inc.

Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.

Share on Social Networks: